Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Nancy_Simonian
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focusesOn |
genetic diseases
cancer therapeutics gene control medicines |
| gptkbp:foundedYear |
2011
|
| gptkbp:founder |
gptkb:Richard_A._Young
gptkb:David_S._Park gptkb:Nadya_Dimitrova |
| gptkbp:headquartersLocation |
gptkb:Cambridge,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Syros Pharmaceuticals
|
| gptkbp:industry |
gptkb:biotechnology
pharmaceuticals |
| gptkbp:notableProduct |
gptkb:SY-1365
gptkb:SY-2101 gptkb:SY-5609 |
| gptkbp:publiclyTraded |
true
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:SYRS
|
| gptkbp:website |
https://www.syros.com/
|
| gptkbp:bfsParent |
gptkb:Mark_J._Alles
gptkb:Srinivas_Akkaraju gptkb:Vicki_Sato gptkb:Tyme_Technologies gptkb:Ropes_&_Gray_LLP |
| gptkbp:bfsLayer |
7
|